Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP ‐1 and modulating gut microbiota
Heng Wu, Jing Wei, Xiumiao Zhao, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 23

Showing 23 citing articles:

Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism
Ruizhe Zhu, Yilin Fang, Hongyu Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 82
The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A Literature Review
Angela Dziedzic, Karina Maciak, Katarzyna Bliźniewska-Kowalska, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 1054-1054
Open Access | Times Cited: 13
T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics
Jian‐Hong Liao, Hong Pan, Guojun Huang, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114086-114086
Open Access | Times Cited: 10
Taming microglia: the promise of engineered microglia in treating neurological diseases
Echo Yongqi Luo, Ryohichi Sugimura
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease
Chuanqi Chu, Leilei Yu, Yiwen Li, et al.
Food & Function (2023) Vol. 14, Iss. 8, pp. 3406-3422
Closed Access | Times Cited: 18
Probiotics: Bridging the interplay of a healthy gut and psychoneurological well‐being
Ashish Kumar Meher, Biswajeet Acharya, Prafulla Kumar Sahu
Food Bioengineering (2024) Vol. 3, Iss. 1, pp. 126-147
Open Access | Times Cited: 7
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease
Büşra Aktaş, Belma Aslım, Deniz Ateş
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Engineered probiotics Clostridium butyricum‐pMTL007‐GLP‐1 improves blood pressure via producing GLP‐1 and modulating gut microbiota in spontaneous hypertension rat models
X Wang, Wen‐jie Chen, Rui Jin, et al.
Microbial Biotechnology (2022) Vol. 16, Iss. 4, pp. 799-812
Open Access | Times Cited: 23
Neuroprotective effect of engineeredClostridiumbutyricum‐pMTL007‐GLP‐1 on Parkinson's disease mice models via promoting mitophagy
Yun Wang, Wen‐jie Chen, Yiyang Han, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 16
Escherichia coli Nissle 1917 Protects against Sepsis-Induced Intestinal Damage by Regulating the SCFA/GPRs Signaling Pathway
Yajie Wang, Huan Deng, Lin Xiao, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1622-1622
Open Access | Times Cited: 5
Administration of a Next‐Generation Probiotic Escherichia coli Nissle 1917‐GLP‐1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes
Jie Luo, Yilin Fang, Zhanghua Qi, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2025) Vol. 2025, Iss. 1
Open Access
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Rahul Kumar, Rahul Kumar
International review of neurobiology (2025)
Closed Access
The link between the gut microbiome, inflammation, and Parkinson’s disease
Shiqing Nie, Yuan Ge
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 22, pp. 6737-6749
Closed Access | Times Cited: 9
Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics
Jia Wei Hor, Tzi Shin Toh, Shen‐Yang Lim, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1507-1518
Open Access | Times Cited: 2
Advancements in gene editing technologies for probiotic-enabled disease therapy
Lixuan Wang, Jing Hu, Kun Li, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110791-110791
Open Access | Times Cited: 2
Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice
Baoxiang Wang, Lihua Geng, Jing Wang, et al.
Marine Drugs (2024) Vol. 22, Iss. 5, pp. 193-193
Open Access | Times Cited: 1
The Next-Generation Probiotic E. coli 1917-pSK18a-MT Ameliorates Cadmium-Induced Liver Injury by Surface Display of Metallothionein and Modulation of Gut Microbiota
Yan Qiu Zhang, Hong Huang, Chuanlin Luo, et al.
Nutrients (2024) Vol. 16, Iss. 10, pp. 1468-1468
Open Access | Times Cited: 1
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
Zhiqiang Ke, Qianqian Ma, Xiaonan Ye, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116471-116471
Closed Access | Times Cited: 1
From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes
Frances Widjaja, Ivonne M.C.M. Rietjens
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2658-2658
Open Access | Times Cited: 3
Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer’s disease
Moeka Nakashima, Naoko Suga, Akari Fukumoto, et al.
International Journal of Physiology Pathophysiology and Pharmacology (2024) Vol. 16, Iss. 5, pp. 96-110
Closed Access
Advanced technologies for biomedical applications by emerging researchers in Asia‐Pacific
Weiping Wang, Chenjie Xu, Jin‐Wook Yoo
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 1
Page 1

Scroll to top